PDS Biotechnology Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -15.2% | – | – | – | – | -0.9% | +0.0% | -0.5% | -1.4% | -0.1% | +62.1% | -88.1% | +542.5% | +0.4% | -80.7% | +0.0% | +0.0% | +5.0% | +0.0% | 0.0% | +0.0% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +11.9% | +18.3% | -23.0% | +56.7% | +17.6% | -80.2% | -92.3% | +150.0% | +112.3% | +83.2% | -2.8% | -26.5% | +46.2% | -28.3% | +45.7% | +20.2% | -43.0% | +95.6% | +33.4% | -8.1% | +52.3% | -27.1% | +15.7% | +271.1% | -63.8% | +37.0% | -19.4% | +15.8% | -10.2% | -32.5% | +50.3% | -33.4% | +28.7% | -27.7% | +8.6% | -3.7% | -21.5% | -5.5% | – | |
| – | +17.1% | +1.0% | -0.7% | -4.4% | +32.6% | -11.5% | -28.8% | -1.4% | -9.1% | +30.7% | -39.0% | +28.7% | -47.1% | +26.9% | -26.1% | +21.3% | -26.0% | +19.7% | +43.1% | +39.8% | -10.4% | +13.1% | +0.4% | -12.2% | -8.9% | +34.2% | +31.1% | -13.2% | -34.2% | +26.8% | +22.5% | -18.8% | -16.1% | +15.7% | +4.1% | +4.5% | -36.3% | +134,928.9% | -99.9% | – | |
| – | +6.4% | +7.8% | +11.5% | -17.1% | +47.9% | +8.1% | -66.4% | -39.2% | -3.6% | +43.8% | -13.5% | +36.9% | -55.4% | +45.8% | -22.7% | +33.1% | +3.1% | -24.3% | +67.5% | +36.4% | -9.2% | +34.1% | -16.4% | +2.6% | +158.6% | -49.9% | +34.7% | -17.1% | -1.1% | -3.0% | -14.0% | +17.2% | -27.8% | +24.0% | -16.3% | +6.8% | -18.0% | -2.3% | -0.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +29.7% | -2.3% | +10.4% | +12.8% | -0.7% | -99.8% | -16.2% | +17.2% | +151,452,156.4% | -100.0% | -100.0% | – | – | +0.0% | -100.0% | – | – | – | – | – | – | -100.0% | +1,207.8% | +94.8% | +761.6% | -22.7% | +3.0% | +7.4% | +9.9% | +0.0% | +1.1% | +2.3% | -9.8% | -15.1% | +130.4% | -46.4% | -3.3% | -8.8% | +233.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -157.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -592.1% | – | +75.5% | +26.7% | -1,308.0% | – | -56.1% | -100.0% | – | – | – | – | – | – | -85.7% | +491.0% | -108.0% | – | – | – | – | -100.1% | – | – | – | -100.1% | – | – | – | +150.0% | -17,383,480.0% | – | – | -100.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -157.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -156.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.